drugset
drugset / Trial / NCT02252497

Tranexamic Acid in Total Hip Arthroplasty.

NCT02252497 ↗

Phase 4 Completed 168 enrolled University Hospital of Saint-Etienne
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare a single preoperative dose of 1g of tranexamic acid (TXA) versus a preoperative dose of 1g of TXA followed by a continuous infusion of 1g over height hours on blood loss.

Timeline

Start
2014-04
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.